Search Results

Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation

Authors: Keller, Guillermo A.; Ponte, Marcelo L.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 105-111(7)

Publisher: Bentham Science Publishers

The Lesser of Two Adverse Reactions

Authors: Chakraborti, Chayan; Egan, John

Source: Joint Commission Journal on Quality and Patient Safety, Volume 36, Number 1, January 2010 , pp. 22-27(6)

Publisher: Joint Commission Resources

Ondansetron and seizures

Authors: Singh, Niranjan N.; Rai, Ajitesh; Selhorst, John B.; Acharya, Jayant N.

Source: Epilepsia, Volume 50, Number 12, December 2009 , pp. 2663-2666(4)

Publisher: Blackwell Publishing

Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Preliminary, Single-Blind, Prospective Study

Authors: Pallanti, Stefano; Bernardi, Silvia; Antonini, Sarah; Singh, Nikhilesh; Hollander, Eric

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1047-1055(9)

Publisher: Adis International

Ondansetron: Severe bradycardia: 2 case reports

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 31-31(1)

Publisher: Adis International

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II

Author: Zhou, Shu-Feng

Source: Clinical Pharmacokinetics, Volume 48, Number 12, 1 December 2009 , pp. 761-804(44)

Publisher: Adis International

Droperidol and ondansetron in vitro electrophysiological drug interaction study

Authors: Weissenburger, Jacques; Funck-Brentano, Christian; Jaillon, Patrice; Charbit, Beny

Source: Fundamental & Clinical Pharmacology, Volume 23, Number 6, December 2009 , pp. 719-726(8)

Publisher: Blackwell Publishing

Palonosetron: In the Prevention of Nausea and Vomiting

Authors: Yang, Lily P.H.; Scott, Lesley J.

Source: Drugs, Volume 69, Number 16, 12 November 2009 , pp. 2257-2278(22)

Publisher: Adis International

Aprepitant: A Review of its Use in the Prevention of Nausea and Vomiting

Authors: Curran, Monique P.; Robinson, Dean M.

Source: Drugs, Volume 69, Number 13, 10 September 2009 , pp. 1853-1878(26)

Publisher: Adis International

Assess the risk of chemotherapy-induced nausea and vomiting, then choose the appropriate prophylactic regimen

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 10, October 2009 , pp. 17-21(5)

Publisher: Adis International

Understanding the mechanism for paradoxical effect of ionized and unionized chitosan: Orodispersible tablets of Ondansetron Hydrochloride

Authors: Goel, Honey; Vora, Nishant; Tiwary, Ashok K.; Rana, Vikas

Source: Pharmaceutical Development and Technology, Volume 14, Number 5, October 2009 , pp. 476-484(9)

Publisher: Informa Healthcare

Ondansetron: an effective treatment for the withdrawal symptoms of opioids?

Authors: Chu, Larry F; Clark, J David

Source: Therapy, Volume 6, Number 5, September 2009 , pp. 637-640(4)

Publisher: Future Medicine

Role of antiemetic drugs for the treatment of acute gastroenteritis in children

Author: Vreeman, Rachel C

Source: Pediatric Health, Volume 3, Number 4, August 2009 , pp. 337-341(5)

Publisher: Future Medicine

Complementary and alternative medicine in the treatment of substance use disorders—a review of the evidence

Authors: BEHERE, RISHIKESH V.; MURALIDHARAN, KESAVAN; BENEGAL, VIVEK

Source: Drug and Alcohol Review, Volume 28, Number 3, May 2009 , pp. 292-300(9)

Publisher: Blackwell Publishing

Ondansetron for the Prevention of Seasickness in Susceptible Sailors: An Evaluation at Sea

Authors: Hershkovitz, Dov; Asna, Noam; Shupak, Avi; Kaminski, Gil; Bar, Ronen; Tal, Dror

Source: Aviation, Space, and Environmental Medicine, Volume 80, Number 7, July 2009 , pp. 643-646(4)

Publisher: Aerospace Medical Association

Nasal administration of ondansetron using a novel microspheres delivery system

Authors: Mahajan, Hitendra S.; Gattani, Surendra G.

Source: Pharmaceutical Development and Technology, Volume 14, Number 2, April 2009 , pp. 226-232(7)

Publisher: Informa Healthcare

Mechanisms involved in the antinociceptive and anti-inflammatory effects of bis selenide in mice

Authors: Jesse, Cristiano R.; Savegnago, Lucielli; Nogueira, Cristina W.

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 5, May 2009 , pp. 623-630(8)

Publisher: Pharmaceutical Press

From Nature to Drug Discovery: The Indole Scaffold as a `Privileged Structure'

Authors: de Sa Alves, Fernando R.; Barreiro, Eliezer J.; Manssour Fraga, Carlos A.l.b.e.r.t.o.

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 7, June 2009 , pp. 782-793(12)

Publisher: Bentham Science Publishers

Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers

Authors: Ramesh, Salvi Tushar; Asad, Mohammed; Dhamanigi, Sunil Samson; Prasad, V. Satya

Source: Fundamental & Clinical Pharmacology, Volume 23, Number 3, June 2009 , pp. 303-309(7)

Publisher: Blackwell Publishing

Efficacy of orally disintegrating ondansetron in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomised, double-blind placebo controlled study

Authors: Grover, V. K.; Mathew, P. J.; Hegde, H.

Source: Anaesthesia, Volume 64, Number 6, June 2009 , pp. 595-600(6)

Publisher: Blackwell Publishing